Hirota Fujiki - Search Results

Year	Number of Results
2002	3
2003	1
2004	1
2005	5
2006	4
2007	2
2008	5
2009	2
2010	5
2011	2
2012	4
2013	4
2014	5
2015	2
2016	1
2017	3
2018	3
2021	1
2022	0

1

Tumor promoters: from chemicals to inflammatory proteins.

Fujiki H, Sueoka E, Suganuma M. Fujiki H, et al. J Cancer Res Clin Oncol. 2013 Oct;139(10):1603-14. doi: 10.1007/s00432-013-1455-8. Epub 2013 Jun 12. J Cancer Res Clin Oncol. 2013. PMID: 23756937 Review.

2

Human gastric cancer development with TNF-α-inducing protein secreted from Helicobacter pylori.

Suganuma M, Watanabe T, Yamaguchi K, Takahashi A, Fujiki H. Suganuma M, et al. Among authors: fujiki h. Cancer Lett. 2012 Sep 28;322(2):133-8. doi: 10.1016/j.canlet.2012.03.027. Epub 2012 Mar 27. Cancer Lett. 2012. PMID: 22459353 Review.

3

Role of TNF-α-Inducing Protein Secreted by Helicobacter pylori as a Tumor Promoter in Gastric Cancer and Emerging Preventive Strategies.

Suganuma M, Watanabe T, Sueoka E, Lim IK, Fujiki H. Suganuma M, et al. Among authors: fujiki h. Toxins (Basel). 2021 Mar 1;13(3):181. doi: 10.3390/toxins13030181. Toxins (Basel). 2021. PMID: 33804551 Free PMC article. Review.

4

Green tea: an effective synergist with anticancer drugs for tertiary cancer prevention.

Fujiki H, Suganuma M. Fujiki H, et al. Cancer Lett. 2012 Nov 28;324(2):119-25. doi: 10.1016/j.canlet.2012.05.012. Epub 2012 May 21. Cancer Lett. 2012. PMID: 22626556 Review.

5

Tumor promoters--microcystin-LR, nodularin and TNF-α and human cancer development.

Fujiki H, Suganuma M. Fujiki H, et al. Anticancer Agents Med Chem. 2011 Jan;11(1):4-18. doi: 10.2174/187152011794941163. Anticancer Agents Med Chem. 2011. PMID: 21269254 Review.

6

Challenging the effectiveness of green tea in primary and tertiary cancer prevention.

Fujiki H, Imai K, Nakachi K, Shimizu M, Moriwaki H, Suganuma M. Fujiki H, et al. J Cancer Res Clin Oncol. 2012 Aug;138(8):1259-70. doi: 10.1007/s00432-012-1250-y. Epub 2012 Jun 15. J Cancer Res Clin Oncol. 2012. PMID: 22699930 Review.

7

Carcinogenic aspects of protein phosphatase 1 and 2A inhibitors.

Fujiki H, Suganuma M. Fujiki H, et al. Prog Mol Subcell Biol. 2009;46:221-54. doi: 10.1007/978-3-540-87895-7_8. Prog Mol Subcell Biol. 2009. PMID: 19184590 Review.

8

Biophysical Approach to Mechanisms of Cancer Prevention and Treatment with Green Tea Catechins.

Suganuma M, Takahashi A, Watanabe T, Iida K, Matsuzaki T, Yoshikawa HY, Fujiki H. Suganuma M, et al. Among authors: fujiki h. Molecules. 2016 Nov 18;21(11):1566. doi: 10.3390/molecules21111566. Molecules. 2016. PMID: 27869750 Free PMC article. Review.

9

Green tea: cancer preventive beverage and/or drug.

Fujiki H, Suganuma M, Imai K, Nakachi K. Fujiki H, et al. Cancer Lett. 2002 Dec 15;188(1-2):9-13. doi: 10.1016/s0304-3835(02)00379-8. Cancer Lett. 2002. PMID: 12406542 Review.

10

Human cancer stem cells are a target for cancer prevention using (-)-epigallocatechin gallate.

Fujiki H, Sueoka E, Rawangkan A, Suganuma M. Fujiki H, et al. J Cancer Res Clin Oncol. 2017 Dec;143(12):2401-2412. doi: 10.1007/s00432-017-2515-2. Epub 2017 Sep 23. J Cancer Res Clin Oncol. 2017. PMID: 28942499 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results